Interleukin 1β-Responsive MicroRNA-146a Is Critical for the Cytokine-Induced Tolerance and Cross-Tolerance to Toll-Like Receptor Ligands

Journal of Innate Immunity

Volumn 7, Issue 4, 2015, Pages 428-440

  Nahid, Md A ^a   Satoh, Minoru ^b,c,d   Chan, Edward K L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b Immunology and Laboratory Medicine   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Lipopolysaccharide; microRNA; Peptidoglycan; Toll like receptor ligands

Indexed keywords

ALPHA INTERFERON; FLAGELLIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 132; MICRORNA 146A; MICRORNA 155; MICRORNA 16; MICRORNA 21; MICRORNA 212; PEPTIDOGLYCAN; RANTES; TOLL LIKE RECEPTOR LIGAND; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, HUMAN; IRAK1 PROTEIN, MOUSE; MIRN146 MICRORNA, HUMAN; MIRN146 MICRORNA, MOUSE; TOLL LIKE RECEPTOR;

A549 CELL LINE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INNATE IMMUNITY; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ANIMAL; GENETICS; IMMUNOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; MICRORNAS; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTORS;

EID: 84937519093     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000371517     Document Type: Article

References (54)

1. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
2. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
3. Schroder K, Zhou R, Tschopp J: The NLRP3 inflammasome: a sensor for metabolic danger Science 2010; 327: 296-300.
4. Schroder K, Tschopp J: The inflammasomes. Cell 2010; 140: 821-832.
5. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, van de Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, Funk CJ, Mason RJ, Kullberg BJ, Rubartelli A, van der Meer JW, Dinarello CA: Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009; 113: 2324-2335.
6. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M Jr: IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 2013; 9:e1003330.
7. Janssens S, Beyaert R: Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 2003; 11: 293-302.
8. Palm NW, Medzhitov R: Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009; 227: 221-233.
9. Iwasaki A, Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291-295.
10. Maedler K, Dharmadhikari G, Schumann DM, Storling J: Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther 2009; 9: 1177-1188.
11. Nahid MA, Pauley KM, Satoh M, Chan EKL: miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009; 284: 34590-34599.
12. Nahid MA, Yao B, Dominguez-Gutierrez PR, Kesavalu L, Satoh M, Chan EKL: Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by MIR-132 and MIR-212. J Immunol 2013; 190: 1250-1263.
13. Nahid MA, Satoh M, Chan EKL: MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011; 8: 388-403.
14. Nahid MA, Satoh M, Chan EKL: Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011; 186: 1723-1734.
15. O'Neill LA, Sheedy FJ, McCoy CE: MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011; 11: 163-175.
16. Ambros V: The functions of animal microRNAs. Nature 2004; 431: 350-355.
17. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD: MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-845.
18. Lodish HF, Zhou B, Liu G, Chen CZ: Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-130.
19. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X: MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009; 183: 2150-2158.
20. Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R: LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J 2009; 23: 2898-2908.
21. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA: Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA MIR-21. Nat Immunol 2010; 11: 141-147.
22. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaB-dependent induction of microRNA MIR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486.
23. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609.
24. Imaizumi T, Tanaka H, Tajima A, Yokono Y, Matsumiya T, Yoshida H, Tsuruga K, Aizawa-Yashiro T, Hayakari R, Inoue I, Ito E, Satoh K: IFN-gamma and TNF-alpha synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am J Nephrol 2010; 32: 462-468.
25. Ferlito M, Romanenko OG, Ashton S, Squadrito F, Halushka PV, Cook JA: Effect of crosstolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J Leukoc Biol 2001; 70: 821-829.
26. Lindsay MA: microRNAs and the immune response. Trends Immunol 2008; 29: 343-351.
27. Alves-Rosa F, Vulcano M, Beigier-Bompadre M, Fernandez G, Palermo M, Isturiz MA: Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice. Clin Exp Immunol 2002; 128: 221-228.
28. Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EKL: Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods 2006; 317: 38-44.
29. Jung HM, Phillips BL, Patel RS, Cohen DM, Jakymiw A, Kong WW, Cheng JQ, Chan EKL: Keratinization-associated MIR-7 and MIR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 2012; 287: 29261-29272.
30. Jung HM, Patel RS, Phillips BL, Wang H, Cohen DM, Reinhold WC, Chang LJ, Yang LJ, Chan EKL: Tumor suppressor MIR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNAmRNA interactions. Mol Biol Cell 2013; 24: 1638-1648.
31. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-delta delta C(T) method. Methods 2001; 25: 402-408.
32. Furuta K, Chan EKL, Kiyosawa K, Reimer G, Luderschmidt C, Tan EM: Heterochromatin protein HP1Hsbeta (p25beta) and its localization with centromeres in mitosis. Chromosoma 1997; 106: 11-19.
33. Moreno RD, Ramalho-Santos J, Chan EKL, Wessel GM, Schatten G: The Golgi apparatus segregates from the lysosomal/acrosomal vesicle during rhesus spermiogenesis: structural alterations. Dev Biol 2000; 219: 334-349.
34. Ceribelli A, Yao B, Dominguez-Gutierrez PR, Nahid MA, Satoh M, Chan EKL: MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 2011; 13: 229.
35. Ceribelli A, Satoh M, Chan EKL: MicroRNAs and autoimmunity. Curr Opin Immunol 2012; 24: 686-691.
36. Ikejima T, Okusawa S, Ghezzi P, van der Meer JW, Dinarello CA: Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 1990; 162: 215-223.
37. Tiwari RL, Singh V, Singh A, Barthwal MK: IL-1R-associated kinase-1 mediates protein kinase C-delta-induced IL-1beta production in monocytes. J Immunol 2011; 187: 2632-2645.
38. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA: Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008; 180: 5689-5698.
39. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP: The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
40. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
41. Lin SC, Lo YC, Wu H: Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465: 885-890.
42. Jessop JJ, Hoffman T: Production and release of IL-1 beta by human peripheral blood monocytes in response to diverse stimuli: possible role of 'microdamage' to account for unregulated release. Lymphokine Cytokine Res 1993; 12: 51-58.
43. Li J, Huang J, Dai L, Yu D, Chen Q, Zhang X, Dai K: miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther 2012; 14:R75.
44. Ouyang YB, Xu L, Yue S, Liu S, Giffard RG: Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neurosci Lett 2014; 565: 53-58.
45. Zhao JL, Starczynowski DT: Role of microRNA-146a in normal and malignant hematopoietic stem cell function. Front Genet 2014; 5: 219.
46. So AY, Zhao JL, Baltimore D: The Yin and Yang of microRNAs: leukemia and immunity. Immunol Rev 2013; 253: 129-145.
47. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P: MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009; 106: 2735-2740.
48. Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27: 519-550.
49. Nahid MA, Rivera M, Lucas A, Chan EKL, Kesavalu L: Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/-mice during experimental periodontal disease. Infect Immun 2011; 79: 1597-1605.
50. Yoo HG, Shin BA, Park JS, Lee KH, Chay KO, Yang SY, Ahn BW, Jung YD: IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells. Biochem Biophys Res Commun 2002; 298: 251-256.
51. Cheng CY, Kuo CT, Lin CC, Hsieh HL, Yang CM: IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells. Br J Pharmacol 2010; 160: 1595-1610.
52. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181: 1887-1892.
53. Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 1997; 158: 2898-2903.
54. Leon P, Redmond HP, Shou J, Daly JM: Interleukin 1 and its relationship to endotoxin tolerance. Arch Surg 1992; 127: 146-151.